What's new? Log in Free sign up

Filing search / Alkermes plc / "Health Care"

Search information

Alkermes plc

Companies

"Health Care"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

45 results

Newest first Best match first

ALKS Alkermes plc

pursuant to our FSS contract with the Department of Veterans Affairs. Under the Veterans Health Care Act of 1992 (the “VHC Act”), we are required … are recorded net of reserves established for applicable discounts and allowances that are offered within contracts with the Company’s customers, health care providers

12 Feb 25

5:18pm

ALKS Alkermes plc

Definitive proxy

five percent of this class of securities, except for Vanguard Health Care Fund. Each of Wellington Management, Wellington Holdings and Wellington … of the US Vaccines Business Unit from 2011 to 2014 and as National Sales Leader, Specialty Commercial Operations-Women’s Health Care from 2009 to 2011

15 Apr 24

4:18pm

ALKS Alkermes plc

Preliminary proxy

of this class of securities, except for Vanguard Health Care Fund. Each of Wellington Management, Wellington Holdings and Wellington Advisors beneficially … Business Unit from 2011 to 2014 and as National Sales Leader, Specialty Commercial Operations-Women’s Health Care from 2009 to 2011. Prior to that, Mr

5 Apr 24

5:28pm

ALKS Alkermes plc

to educate health care providers of the drug’s risks, limitations on who may prescribe or dispense the drug, or other measures that the FDA deems … Administration pursuant to our FSS contract with the Department of Veterans Affairs. Under the Veterans Health Care Act of 1992 (the “VHC Act”), we are required

21 Feb 24

4:01pm

ALKS Alkermes plc

Transferred Entity, have been subject to an Action that has resulted in exclusion from a governmental or private health care program under which … such Person could be excluded from participating in any U.S. federal health care programs and each of the Purchasers has appropriate policies

21 Feb 24

4:01pm

Alkermes Completes Separation of Oncology Business

Alkermes Presents First Clinical Data for Orexin 2 Receptor Agonist ALKS 2680 at World Sleep Congress

Quarterly report

26 Jul 23

4:14pm

Proxy in contested solicitation

ii7pd7986tv35z pmr

Preliminary revised proxy

wgjixq4rwnu6uv81xy

Preliminary proxy with contested solicitation

Annual report (amended)

26 Apr 23

4:18pm

Proxy in contested solicitation

02q905s1en ayn3u

Preliminary proxy with contested solicitation

Annual report (amended)

29 Apr 22

4:06pm

wi4dialuk o1ejj00p2

Definitive proxy

18 Apr 22

9:24am

Preliminary proxy

8 Apr 22

4:27pm

16 Feb 22

9:12am

Definitive proxy

10 May 21

9:27am

s3ibc88b48zwwifx

Preliminary proxy

30 Apr 21

8:38am

Prev
1
2
3
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.